Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers
about
The position of mefloquine as a 21st century malaria chemoprophylaxisMefloquine for preventing malaria in non-immune adult travellersAdverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?Adverse events associated with mefloquine. Study in returned travellers confirms authors' findingsChloroquine stimulates Cl- secretion by Ca2+ activated Cl- channels in rat ileumSporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trialMalaria: prevention in travellers.Hepatitis during chloroguanide prophylaxis.Mefloquine for malaria chemoprophylaxis 1992-1998: a review.Malaria at Christmas: risks of prophylaxis versus risks of malaria.Extracts from "Clinical Evidence". Malaria: prevention in travellers.Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.Mefloquine for preventing malaria in non-immune adult travellers.Somatic hypotheses of war syndromes.Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.Antiparasitic agent atovaquonePsychiatric side effects of non-psychiatric drugs.Mefloquine: contraindicated in patients with mood, psychotic or seizure disordersA randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of single enantiomer (+)-mefloquine compared with racemic mefloquine in healthy personsMefloquine induces dose-related neurological effects in a rat model.Malaria Chemoprophylaxis and Self-Reported Impact on Ability to Work: Mefloquine Versus Doxycycline.The travelling athlete: issues relating to the Commonwealth Games, Malaysia, 1998.A small-fish model for behavioral-toxicological screening of new antimalarial drugs: a comparison between erythro- and threo-mefloquine.Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquineMalaria chemoprophylaxis: when should we use it and what are the options?Quinacrine induced mood disturbance--the unmasking of bipolar affective disorder.Signal detection to identify serious adverse events (neuropsychiatric events) in travelers taking mefloquine for chemoprophylaxis of malariaAdverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patientsAssessment of safety of the major antimalarial drugs.Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study.Investigation of the in vitro gender-specific partitioning of mefloquine in malarial infected red blood cells and plasmaGender-specific distribution of mefloquine in the blood following the administration of therapeutic doses.Epilepsy triggered by mefloquine in an adult traveler to Uganda.Pre-travel malaria chemoprophylaxis counselling in a public travel medicine clinic in São Paulo, Brazil.Adverse neuropsychiatric effects of antimalarial drugs.Malaria, mefloquine and oil-workers.Imported malaria in children in the UK.The practice of travel medicine: guidelines by the Infectious Diseases Society of America.Epileptogenic potential of mefloquine chemoprophylaxis: a pathogenic hypothesis.Neuropsychiatric Outcomes After Mefloquine Exposure Among U.S. Military Service Members.
P2860
Q21034126-3CE41DAB-F491-4992-AA2B-F2B8498B730EQ24243321-D13EBE25-A4A4-4F68-9EDD-D5DBAB8F5E69Q24806081-C30CAB19-27BA-43FA-881D-79A8BE3AD6DBQ28379377-8702EBF8-462E-458E-AA0B-3E731BF88A02Q28539357-C9317026-74D9-4C73-9EB1-1B3646A8E747Q28544964-2E9DBEDB-AF61-41FE-B01B-864CF51AD288Q30479499-484C497E-D8BB-4238-BBCF-DC2FB1805F6FQ31988635-067626BB-F464-45D1-8E10-F31D7B43993AQ33669693-B7A0B6E7-FF09-479E-A463-E376C42079BEQ33792782-71D80BFD-7C72-4933-ACBE-6040C454D955Q33801237-150ED7DC-405D-4913-932B-24B75BD5A5C5Q33806574-B4364C95-BAF6-48DB-B0C7-FBFA7CC7719EQ33908534-6F560167-246D-4F8A-942C-7B987AAFB81EQ33908700-782D5C0A-D66A-4F27-9AE1-D9625A550504Q34088738-43349309-7AED-4CEA-AD24-0F307BBE5473Q34107885-6AEEF715-B3A1-4ECA-A9FA-648CBDC5AEACQ34138808-876BF3E6-8580-49AF-9064-F1C4BA7ED70EQ34292338-F071C852-8DBB-4405-AD73-71FEB8E24FB0Q34341756-A2387FAE-8267-4564-9A0D-83E67333F258Q34509705-159B7A95-E194-4BD2-B1E0-8F133041A592Q34673443-59F0D670-6814-4010-B9B4-976371FC6DBDQ35556611-E1CC5BE4-0209-42F3-96E2-EA96DCD9FC5BQ35606501-F76051BD-AE0E-471F-A26E-301DD500F6A1Q35826033-5C46EDB6-9C81-44C6-928E-055816ED8844Q35917341-A3982FDB-CEB3-4647-9766-C5E3315BD737Q36069944-5FC743EA-42EA-4565-934C-C211DEF21056Q36184868-2DE1F1A5-D6F3-491A-BB95-7AA4A2CEC293Q36278433-76FAD8AB-A99F-4238-AE93-F782B277ECC8Q36945007-D8E30E95-E509-49E8-81C2-E41D06AB8862Q37044939-957950F1-8497-4CD6-A12F-FAFE5C2CFFBBQ37225808-9F9D5B07-553A-4C2E-B1AF-8713AF708CC0Q37511902-D607B87A-0AA0-4333-84A3-F6791A6D2B95Q37576127-42FB8396-B4CF-4A48-B4FE-366F92F1DCA5Q37630954-9EC714F3-B204-4A8D-94B7-9801698F0525Q38808162-ECCCD041-90A1-4920-BF29-94D1C564A992Q38893657-6D5C7DC6-DF19-4CBB-85ED-C1E6C1B69604Q38919009-E532978B-4DC5-4DF1-857F-DCE2ECA3ACC1Q39067681-AA970E4C-2D69-485E-B0F9-53C9299D0DA3Q39957773-8AE32C36-693A-4E87-82CB-358A9A27C82BQ40384895-B2A15413-413D-4B4E-B18A-78EC5D7DE4CE
P2860
Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Comparison of adverse events a ...... telephone survey of travellers
@ast
Comparison of adverse events a ...... telephone survey of travellers
@en
Comparison of adverse events a ...... telephone survey of travellers
@nl
type
label
Comparison of adverse events a ...... telephone survey of travellers
@ast
Comparison of adverse events a ...... telephone survey of travellers
@en
Comparison of adverse events a ...... telephone survey of travellers
@nl
prefLabel
Comparison of adverse events a ...... telephone survey of travellers
@ast
Comparison of adverse events a ...... telephone survey of travellers
@en
Comparison of adverse events a ...... telephone survey of travellers
@nl
P2093
P356
P1433
P1476
Comparison of adverse events a ...... telephone survey of travellers
@en
P2093
D J Bradley
P D Clarke
P D Emmins
P J Barrett
P2860
P356
10.1136/BMJ.313.7056.525
P407
P577
1996-08-31T00:00:00Z